These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8726606)

  • 1. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation.
    Lindsay CA; Bawdon R; Quigley R
    Pharmacotherapy; 1996; 16(3):458-62. PubMed ID: 8726606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous venovenous hemofiltration with or without extracorporeal membrane oxygenation in children.
    Shaheen IS; Harvey B; Watson AR; Pandya HC; Mayer A; Thomas D
    Pediatr Crit Care Med; 2007 Jul; 8(4):362-5. PubMed ID: 17545928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and children.
    Reed MD; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1995 Jul; 35(7):658-65. PubMed ID: 7560245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
    Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
    Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticarcillin plus clavulanic acid: pharmacokinetic study in renal failure.
    Stathakis C; Bakounsli I; Iatrou C; Boletis J; Kosmidis J
    Chemioterapia; 1987 Jun; 6(2 Suppl):265-7. PubMed ID: 3509408
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
    Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
    Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.
    Nei SD; Wittwer ED; Kashani KB; Frazee EN
    Pharmacotherapy; 2015 Aug; 35(8):e127-30. PubMed ID: 26242293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis.
    Jacobs RF; Trang JM; Kearns GL; Warren RH; Brown AL; Underwood FL; Kluza RB
    J Pediatr; 1985 Jun; 106(6):1001-7. PubMed ID: 3998937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C in critically ill patients treated with continuous venovenous hemofiltration.
    Baas MC; Bouman CS; Hoek FJ; Krediet RT; Schultz MJ
    Hemodial Int; 2006 Oct; 10 Suppl 2():S33-7. PubMed ID: 17022749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of clavulanic acid and ticarcillin combined.
    Scully BE; Steinman R; Chin NX; Neu HC
    Chemioterapia; 1984 Dec; 3(6):385-9. PubMed ID: 6529781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Extracorporeal Membrane Oxygenation on the New Vancomycin Dosing Regimen in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration.
    Yang CJ; Wu CW; Wu CC
    Ther Drug Monit; 2018 Jun; 40(3):310-314. PubMed ID: 29746432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro adsorption and sieving coefficient of ticarcillin-clavulanate during continuous haemofiltration.
    T P Wan W; Guerra Valero Y; Choi GYS; Ordóñez Mejia JL; Wallis SC; Joynt GM; Lipman J; Gomersall CD; Roberts JA
    Int J Antimicrob Agents; 2019 Aug; 54(2):261-264. PubMed ID: 30904466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary elimination of ticarcillin plus clavulanic acid (Claventin): experimental and clinical study.
    Brogard JM; Jehl F; Blickle JF; Adloff M; Dorner M; Montell H
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):135-44. PubMed ID: 2722309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation.
    Buck ML
    Pharmacotherapy; 1998; 18(5):1082-6. PubMed ID: 9758319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.